Inhibitory effect of lithium on nucleotide hydrolysis and acetylcholinesterase activity in zebrafish (Danio rerio) brain

Neurotoxicology and Teratology

Volumn 33, Issue 6, 2011, Pages 651-657

  Oliveira, Renata da Luz ^a,b   Seibt, Kelly Juliana ^a,b   Rico, Eduardo Pacheco ^c,d   Bogo, Mauricio Reis ^a,b   Bonan, Carla Denise ^a,b  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina INCT TM   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d Instituto Nacional de Ciencia e Tecnologia em Excitotoxicidade e Neuroprotecao (INCT EN)   (Brazil)

Author keywords

Acetylcholinesterase; Ecto 5' nucleotidase; Ectonucleotidases; Lithium chloride; Nucleoside triphosphate diphosphohydrolases; Zebrafish

Indexed keywords

ACETYLCHOLINESTERASE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ECTO 5' NUCLEOTIDASE; LITHIUM CHLORIDE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; GENETIC TRANSCRIPTION; HYDROLYSIS; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; NUCLEOTIDE HYDROLYSIS; PRIORITY JOURNAL; ZEBRA FISH;

ACETYLCHOLINESTERASE; ADENOSINE TRIPHOSPHATASES; ANIMALS; BRAIN; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION; HYDROLYSIS; LITHIUM; MALE; NUCLEOTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ZEBRAFISH;

DANIO RERIO;

EID: 84855911957     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2011.05.005     Document Type: Article

References (60)

1. Allison J.H., Stewart M.A. Reduced brain inositol in lithium-treated rats. Nat New Biol 1971, 233(43):267-268.
2. Altamura A.C., Lietti L., Dobrea C., Benatti B., Arici C., Dell'Osso B. Mood stabilizers for patients with bipolar disorder: the state of the art. Expert Rev Neurother 2011, 11(1):85-99.
3. Appelbaum L., Skariah G., Mourrain P., Mignot E. Comparative expression of p2x receptors and ecto-nucleoside triphosphate diphosphohydrolase 3 in hypocretin and sensory neurons in zebrafish. Brain Res 2007, 1174:66-75.
4. Barcellos C.K., Schetinger M.R.C., Dias R.D., Sarkis J.J.F. In vitro effect of central nervous system active drugs on the ATPase-ADPase activity and acetylcholinesteras activity from cerebral cortex of adult rats. Gen Pharmacol 1998, 31(4):563-567.
5. Barnes J.M., Murphy P.A., Kirkham D., Henley J.M. Interaction of guanine nucleotides with [3H] kainate and 6-[3H] cyano-7-nitroquinoxaline-2,3-dione binding in goldfish brain. J Neurochem 1993, 61:1685-1691.
6. Best J.D., Alderton W.K. Zebrafish: an in vivo model for the study of neurological diseases. Neuropsychiatr Dis Treat 2008, 4(3):567-576.
7. Bertrand C., Chatonnet A., Takke C., Yan Y.L., Postlethwait J., Toutant J.P., et al. Zebrafish acetylcholinesterase is encoded by a single gene localized on linkage group 7. Gene structure and polymorphism; molecular forms and expression pattern during development. J Biol Chem 2001, 5(276(1):464-474.
8. Bertrand D. The possible contribution of neuronal nicotinic acetylcholine receptors in depression. Dialogues Clin Neurosci 2005, 7:207-216.
9. Bhalla P., Chadha V.D., Dhawan D.K. Effectiveness of zinc in modulating lithium induced biochemical and behavioral changes in rat brain. Cell Mol Neurobiol 2007, 27(5):597-607.
10. Bhalla P., Garg M.L., Dhawan D.K. Protective role of lithium during aluminium-induced neurotoxicity. Neurochem Int 2010, 56:256-262.
11. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:218-254.
12. Burnstock G. Cotransmission. Curr Opin Pharmacol 2004, 4:47-52.
13. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 2006, 58:58-86.
14. Burnstock G. Purinergic receptors as future targets for treatment of functional GI disorders. Gut 2008, 57(9):1193-1194.
15. Burnstock G. Purinergic cotransmission. F1000. Biol Rep 2009, 9:1. pii-46.chan.
16. Calabrese J.R., Hirschfeld R.M., Reed M., Davies M.A., Frye M.A., Keck P.E., et al. Impact of bipolar disorder on a US community sample. J Clin Psychiatry 2003, 64(4):425-432.
17. Chakraborty G., Saito M., Mao R.F., Wang R., Vadasz C., Saito M. Lithium blocks ethanol-induced modulation of protein kinases in the developing brain. Biochem Biophys Res Commun 2008, 367:597-602.
18. 2+-ATPase activity. Anal Biochem 1986, 157:375-380.
19. Chaudhary G., Gupta Y.K. Lithium does not synergize the peripheral action of cholinomimetics as seen in the central nervous system. Life Sci 2001, 68(18):2115-2121.
20. Chen W.Y., John J.A., Lin C.H., Lin H.F., Wu S.C., Lin C.H., et al. Expression of metallothionein gene during embryonic and early larval development in zebrafish. Aquat Toxicol 2004, 69(3):215-227.
21. Ellman G.L., Courtney K.D., Andrés J.V., Feartherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961, 7:88-95.
22. Fredholm B.B. Adenosine receptors as drug targets. Exp Cell Res 2010, 1(316(8):1284-1288.
23. Fredholm B.B., Ijzerman A.P., Jacobson K.A., Klotz K.N., Linden J. International Union of Pharmacology: XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001, 2001(53):527-552.
24. Furey M.L., Drevets W.C. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Arch Gen Psychiatry 2006, 63(10):1121-1129.
25. Grignon S., Bruguerolle B. Cerebellar lithium toxicity: a review of recent literature and tentative pathophysiology. Therapie 1996, 51(2):101-106.
26. Ketter T.A. Diagnostic features, prevalence, and impact of bipolar disorder. J Clin Psychiatry 2010, 71(6):e14.
27. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Dev Biol 1996, 93:8455-8459.
28. Kores B., Lader M.H. Irreversible lithium neurotoxicity: an overview. Clin Neuropharmacol 1997, 20(4):283-299.
29. Kszos L.A., Beauchamp J.J., Stewart A.J. Toxicity of lithium to three freshwater organisms and the antagonistic effect of sodium. Ecotoxicology 2003, 12:427-437.
30. Kucenas S., Soto F., Cox J.A., Voigt M.M. Selective labeling of central and peripheral sensory neurons in the developing zebrafish using P2X(3) receptor subunit transgenes. Neuroscience 2006, 138(2):641-652.
31. Ludtmann M.H., Boeckeler K., Williams R.S. Molecular pharmacology in a simple model system: implicating MAP kinase and phosphoinositide signalling in bipolar disorder. Semin Cell Dev Biol 2011, 22(1):105-113.
32. Marinho M.M., de Sousa F.C., de Bruin V.M., Vale M.R., Viana G.S. Effects of lithium, alone or associated with pilocarpine, on muscarinic and dopaminergic receptors and on phosphoinositide metabolism in rat hippocampus and striatum. Neurochem Int 1998, 33(4):299-306.
33. McNulty J., O'Donovan D.J., Leonard B.E. The acute and chronic effects of D-amphetamine, chlorpromazine, amitriptyline and lithium chloride on adenosine 5-triphosphatases in different regions of the rat brain. Biochem Pharmacol 1978, 27(7):1049-1053.
34. Nonaka S., Katsube N., Chuang D.M. Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine. J Pharmacol Exp Ther 1998, 286:539-547.
35. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998, 50:413-492.
36. A receptors to facilitate acetylcholine release in the rat hippocampus. Eur J Pharmacol 2002, 454:31-38.
37. Rico E.P., Senger M.R., Fauth M.G., Dias R.D., Bogo M.R., Bonan C.D. ATP and ADP hydrolysis in brain membranes of zebrafish (Danio rerio). Life Sci 2003, 73:2071-2082.
38. Rico E.P., Rosemberg D.B., Senger M.R., Arizi Mde B., Bernardi G.F., Dias R.D., et al. Methanol alters ecto-nucleotidases and acetylcholinesterase in zebrafish brain. Neurotoxicol Teratol 2006, 28(4):489-496. Jul-Aug.
39. Ronai A.Z., Vizi S.E. The effect of lithium treatment on the acetylcholine content of rat brain. Biochem Pharmacol 1975, 24(19):1819-1820.
40. Robson S.C., Sévigny J., Zimmermann H. The E-NTPDase family of ectonucleotidases: structure-function relationships and pathophysiological significance. Purinergic Signal 2006, 2(2):409-430.
41. Rosemberg D.B., Rico E.P., Senger M.R., Arizi Mde B., Dias R.D., Bogo M.R., et al. Acute and subchronic copper treatments alter extracellular nucleotide hydrolysis in zebrafish brain membranes. Toxicology 2007, 1(236(1-2):132-139.
42. Rubinstein A.L. Zebrafish: from disease modelling to drug discovery. Curr Opin Drug Discov Devel 2003, 6(2):218-223.
43. Schetinger M.R., Morsch V.M., Bonan C.D., Wyse A.T. NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health. Biofactors 2007, 31(2):77-98.
44. Sebastião A.M., Ribeiro J.A. Adenosine receptors and the central nervous system. Handb Exp Pharmacol 2009, 193:471-534.
45. Selderslaghs I.W., Van Rompay A.R., De Coen W., Witters H.E. Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo. Reprod Toxicol 2009, 28(3):308-329.
46. Senger M.R., Rico E.P., Dias R.D., Bogo M.R., Bonan C.D. Ecto-5'-nucleotidase activity in brain membranes of zebrafish (Danio rerio). Comp Biochem Physiol 2004, 139(2):203-207.
47. Shaked I., Zimmermann G., Soreq H. Stress-induced alternative splicing modulations in brain and periphery. Ann N Y Acad Sci 2008, 1148:269-281.
48. Shaldubina A., Agam G., Belmaker R.H. The mechanism of lithium action: state of the art, ten years later. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25:855-866.
49. Shytle R.D., Silver A.A., Lukas R.J., Newman M.B., Sheehan D.V., Sanberg P.R. Nicotinic acetylcholine receptors as targets for antidepressants. Mol Psychiatry 2002, 7:525-535.
50. Soreq H., Seidman S. Acetylcholinesterase-new roles for an old actor. Nat Rev Neurosci 2001, 2(4):294-302.
51. Swann A.C., Marini J.L., Sheard M.H., Maas J.W. Effects of chronic dietary lithium on activity and regulation of (Na, K)-adenosine triphosphatase in rat brain. Biochem Pharmacol 1980, 29:2819-2823.
52. Waring W.S. Management of lithium toxicity. Toxicol Rev 2006, 25(4):221-230.
53. Williams M.B., Jope R.S. Modulation by inositol of cholinergic- and serotonergic-induced seizures in lithium-treated rats. Brain Res 1995, 685:169-178.
54. Wilot L.C., Silva R.S., Ferreira O.J., Bonan C.D., Sarkis J.J.F., Rocha E., et al. Chronic treatment with lithium increases the ecto-nucleotidase activities in rat hippocampal synatosomes. Neurosci Lett 2004, 368:167-170.
55. Wood A.J., Elphick M., Grahame-Smith D.G. Effect of lithium and of other drugs used in the treatment of manic illness on the cation-transporting properties of Na+-K+-ATPase in mouse brain synaptosomes. J Neurochem 1989, 1989(52):1042-1049.
56. Yi M.Q., Liu H.X., Shi X.Y., Liang P., Gao X.W. Inhibitory effects of four carbamate insecticides on acetylcholinesterase of male and female Carassius auratus in vitro. Comp Biochem Physiol C Toxicol Pharmacol 2006, 143:113-116.
57. Yildiz A., Moore C.M., Sachs G.S., Demopulos C.M., Tunca Z., Erbayraktar Z., et al. Lithium-induced alterations in nucleoside triphosphate levels in human brain: a proton-decoupled 31P magnetic resonance spectroscopy study. Psychiatry Res 2005, 138(1):51-59.
58. Yucel K., Taylor V.H., McKinnon M.C., Macdonald K., Alda M., Young L.T., et al. Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment. Neuropsychopharmacology 2008, 33:361-367.
59. Zhong J., Yang X., Yao W., Lee W. Lithium protects ethanol-induced neuronal apoptosis. Biochem Biophys Res Commun 2006, 350:905-910.
60. Zimmermann H. Nucleotide signaling in nervous system development. Eur J Physiol 2006, 452:573-588.